Biotransformation and metabolite elucidation of xenobiotics (notice n° 2980)
000 -LEADER | |
---|---|
fixed length control field | 01916cam a2200313' 4500 |
001 - CONTROL NUMBER | |
control field | UNI0000522 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20161122155536.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 141212s2010 us a b 001 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780470504789 (cloth) |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | DNLM/DLC |
Description conventions | rda |
040 ## - CATALOGING SOURCE | |
Modifying agency | IMIST |
Description conventions | rda |
041 1# - LANGUAGE CODE | |
Language code of text/sound track or separate title | eng |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | QP529 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.9 |
Edition number | 22 |
245 #0 - TITLE STATEMENT | |
Title | Biotransformation and metabolite elucidation of xenobiotics |
Statement of responsibility, etc | edited by Ala F. Nassar. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | Hoboken, N.J. |
Name of publisher, distributor, etc | John Wiley and Sons |
Date of publication, distribution, etc | [2010] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Date of publication, distribution, etc | copyright 2010. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xi, 328 pages |
Other physical details | illustrations |
Dimensions | 25 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Human biotransformation / Andrew Parkinson -- Analytical tools and approaches for metabolite identification in drug metabolism / Yongmei Li -- Tools of choice for accelerating metabolite identification : mass spec technology drives metabolite identification studies forward / Ala Nassar -- Improving drug design : considerations for the structural modification process / Ala Nassar -- Case study : the unanticipated loss of N2 from novel dna alkylating agent laromustine by collision-induced dissociation : novel rearrangements / Ala Nassar, Tukiet T. Lam -- Case study : identification of in vitro metabolite/decomposition products of the novel DNA alkylating agent laromustine / Ala Nassar, TuKiet T. Lam -- Strategies for the detection of reactive intermediates in drug discovery and development / Mark P. Grillo -- Safety testing of drug metabolites : MIST guidance impact on the practice of industrial drug metabolism / J. Greg Slatter. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Xenobiotics |
General subdivision | Metabolism. |
-- | Identification. |
-- | metabolism. |
-- | pharmacology. |
-- | physiology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Metabolites |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Biotransformation (Metabolism) |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Xenobiotics |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Xenobiotics |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Biotransformation |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Discovery |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nassar, Ala F. |
Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 19495 | 615.9 NAS | 0000000022369 | 11/22/2016 | 11/22/2016 | Livre |